Ironwood Pharmaceuticals
IRWD
IRWD
151 hedge funds and large institutions have $2.69B invested in Ironwood Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 52 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+3
Holders Change %
+2.03%
% of All Funds
3.46%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
21
Increased
44
Reduced
52
Closed
17
Calls
$21.8M
Puts
$10.7M
Net Calls
+$11.2M
Net Calls Change
-$3.36M
Top Buyers
| 1 |
BM
Bridger Management
New York
|
+$11.5M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.24M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.23M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.98M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$8.79M |
